Trademark: 98324339
Word
RETINALGENIX HIGH-RESOLUTION RETINAL IMAGING - HOME & REMOTE MONITORING - DNA/RNA GPS PHARMACOGENETIC MAPPING - DIAGNOSTIC TESTING & THERAPEUTICS TESTING DRUG VALIDATION & THERAPEUTICS
Status
Pending
Status Code
641
Status Date
Friday, May 31, 2024
Serial Number
98324339
Mark Type
3
Filing Date
Wednesday, December 20, 2023

Trademark Owner History

Classifications
42 High-Resolution retinal imaging; Home and remote monitoring; DNA/RNA GPS pharmacogenetic mapping; Diagnostic testing and therapeutics testing: Drug validation and therapeutics
The mark consists of the word RetinalGeniX written in stylized font above the words High-Resolution Retinal Imaging - Home & Remote Monitoring - DNA/RNA GPS Pharmacogenetic Mapping - Diagnostic Testing & Therapeutics Testing Drug Validation & Therapeutics. All of this is written over a background with different shaped hexagons.
RETINAL GENICS HIGH RESOLUTION RETINAL IMAGING HOME AND REMOTE MONITORING DNA RNA GPS PHARMACOGENETIC MAPPING DIAGNOSTIC TESTING AND THERAPEUTICS TESTING DRUG VALIDATION AND THERAPEUTICS
Color is not claimed as a feature of the mark.

Trademark Events
Dec 20, 2023
New Application Entered
Apr 1, 2024
New Application Office Supplied Data Entered
May 15, 2024
Assigned To Examiner
May 31, 2024
Non-Final Action E-Mailed
Sep 3, 2024
Application Extension Granted/Receipt Provided
Sep 3, 2024
Application Extension To Response Period - Received
May 31, 2024
Notification Of Non-Final Action E-Mailed
May 31, 2024
Non-Final Action Written

Trademark Alertz updated from USPTO on 2030-01-24